Please use this identifier to cite or link to this item:
http://cmuir.cmu.ac.th/jspui/handle/6653943832/52617
Title: | Evaluation of IgG4 subclass antibody detection by peptide-based ELISA for the diagnosis of human paragonimiasis heterotrema |
Authors: | Pewpan M. Intapan Oranuch Sanpool Penchom Janwan Porntip Laummaunwai Nimit Morakote Yoon Kong Wanchai Maleewong |
Authors: | Pewpan M. Intapan Oranuch Sanpool Penchom Janwan Porntip Laummaunwai Nimit Morakote Yoon Kong Wanchai Maleewong |
Keywords: | Immunology and Microbiology;Medicine |
Issue Date: | 1-Dec-2013 |
Abstract: | A synthetic peptide was prepared based on the antigenic region of Paragonimus westermani pre-procathepsin L, and its applicability for immunodiagnosis for human paragonimiasis (due to Paragonimus heterotremus) was tested using an ELISA to detect IgG4 antibodies in the sera of patients. Sera from other helminthiases, tuberculosis, and healthy volunteers were used as the references. This peptide-based assay system gave sensitivity, specificity, accuracy, and positive and negative predictive values of 100%, 94.6%, 96.2%, 100%, and 88.9%, respectively. Cross reactivity was frequently seen against the sera of fascioliasis (75%) and hookworm infections (50%). Since differential diagnosis between paragonimiasis and fascioliasis can be easily done by clinical presentation and fascioliasis serology, this cross reaction is not a serious problem. Sera from patients with other parasitoses (0-25%) rarely responded to this synthetic antigen. This synthetic peptide antigen seems to be useful for development of a standardized diagnostic system for paragonimiasis. © 2013, Korean Society for Parasitology and Tropical Medicine. |
URI: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84893222853&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/52617 |
ISSN: | 17380006 00234001 |
Appears in Collections: | CMUL: Journal Articles |
Files in This Item:
There are no files associated with this item.
Items in CMUIR are protected by copyright, with all rights reserved, unless otherwise indicated.